PATIENT EDUCATION • RENO + SPARKS
Botox vs Xeomin in Reno: Key Differences, Cost, Results and How to Choose
Medically reviewed by May Belle Fellenz, APRN, MSN, FNP-BC
Founder and Lead Medical Aesthetics Provider · Reviewed September 2026
Two proven neuromodulators. Different formulations. One decision that should start with your anatomy—not a brand name.
Botox® Cosmetic and XEOMIN® are both botulinum toxin type A treatments used to soften expression lines. They share important similarities, but they are not the same product, their units are not interchangeable, and their FDA-approved cosmetic uses are not identical. This guide explains the differences that actually matter for Reno patients.
Schedule an Injectable Consultation
QUICK ANSWER
Neither product is automatically “better.”
For many patients, the more important variables are facial anatomy, muscle strength, treatment area, dose, placement, prior response, budget and the injector’s judgment. Bella Derma offers both Botox and Xeomin so the treatment plan does not have to start with a predetermined brand. For treatment-focused Xeomin information, see our Xeomin in Reno service page. For Bella Derma’s complete consultation and treatment approach, see Botox in Reno.
Botox vs Xeomin in Reno: What Is the Main Difference?
Both products temporarily reduce targeted muscle activity by blocking acetylcholine release at the neuromuscular junction. Botox Cosmetic contains onabotulinumtoxinA; Xeomin contains incobotulinumtoxinA. Both can create subtle, natural-looking softening when the product, dose and injection pattern are appropriate.
The practical difference is not that one is “strong” and the other is “weak.” They are separately manufactured prescription medicines with product-specific labeling, dosing and formulation. That is why a safe comparison begins with what each product is approved to treat and how it is dosed—not with internet claims about one being universally superior.
THE BOTTOM LINE
Choose the treatment plan first. Choose the brand second.
If the injector does not understand your brow position, eyelid anatomy, forehead length, muscle strength, asymmetry and movement pattern, switching brands will not fix a poor treatment plan.
Botox vs Xeomin: Quick Comparison
Here is the high-level comparison before we go deeper.
BOTOX® COSMETIC
OnabotulinumtoxinA
• FDA-approved for moderate to severe frown lines, forehead lines, crow’s feet and vertical platysma bands in adults
• Official site reports results may begin in 24–48 hours, with full results in 30 days
• Results may last up to 4 months
• Long-established aesthetic track record and broad cosmetic labeling
XEOMIN®
IncobotulinumtoxinA
• FDA-approved for temporary improvement of moderate to severe upper facial lines: frown lines, forehead lines and crow’s feet in adults
• Official site says improvement appears gradually, with most patients seeing noticeable improvement within the first month
• Results can last up to 4 months
• Formulated without complexing proteins; inactive ingredients include human albumin and sucrose
Botox and Xeomin share important similarities, but they differ in formulation, current FDA-approved cosmetic areas and Bella Derma pricing. Product-specific dosing still matters.
1. Formulation: Botox and Xeomin Are Not the Same Molecule Package
Botox Cosmetic and Xeomin both contain botulinum toxin type A, but they use different active drug preparations. Botox Cosmetic uses onabotulinumtoxinA. Xeomin uses incobotulinumtoxinA and is manufactured without the accessory or complexing proteins associated with some other botulinum toxin preparations.
That distinction is real, but it is often exaggerated online. “Free of complexing proteins” does not mean Xeomin contains nothing except botulinum toxin. XEOMIN’s consumer information lists human albumin and sucrose as inactive ingredients. It also does not automatically mean Xeomin will look more natural, work faster or last longer in every patient.
Does Xeomin’s formulation reduce resistance?
Immunogenicity is a legitimate scientific topic, and secondary nonresponse can occur. Response can also be affected by dose, treatment frequency, injection pattern, muscle strength and individual biology. The absence of complexing proteins is not a reason to promise that Xeomin will “never stop working.” If a patient has a history of reduced response to a neuromodulator, that deserves a careful medical evaluation rather than a marketing shortcut.
2. FDA-Approved Cosmetic Uses: This Is a Meaningful Difference
As of September 2026, the products overlap substantially in the upper face—but their current U.S. cosmetic labeling is not identical.
Botox Cosmetic
Botox Cosmetic is FDA-approved to temporarily improve the appearance of moderate to severe frown lines, forehead lines, crow’s feet and vertical bands connecting the neck and jaw (platysma bands) in adults.
Xeomin
Xeomin is FDA-approved to temporarily improve moderate to severe upper facial lines—frown lines, forehead lines and crow’s feet in adults.
Official references: Botox Cosmetic · Xeomin Aesthetic
Providers may use botulinum toxins off-label when medically appropriate, but an off-label use should be identified as such and discussed during informed consent.
3. Botox Units and Xeomin Units Are Not Interchangeable
This is one of the most important facts in the entire comparison. A “unit” is a measure defined for a specific botulinum toxin product. The Botox Cosmetic prescribing information explicitly states that its units are not the same as, or comparable to, those of another botulinum toxin product. Xeomin labeling likewise instructs clinicians that its dose may differ from other botulinum toxins.
You may see studies that use particular conversion ratios in specific treatment areas, but that is not permission to treat every patient with a universal brand-to-brand conversion formula. Dosing must follow the product, indication, anatomy and clinical judgment.
IMPORTANT
Do not compare price per unit across brands as though the units are identical.
A lower advertised price per Xeomin unit or Botox unit does not automatically mean a cheaper treatment. The meaningful comparison is the recommended treatment plan, total price, injector experience and expected outcome.
4. Onset and Duration: More Similar Than Social Media Suggests
Patients often ask which product “kicks in faster” or “lasts longer.” There can be individual differences, but the evidence and official product information do not support a simple rule that one brand always wins.
Botox Cosmetic
The official Botox Cosmetic site says patients may start to see results in 24–48 hours, with full results assessed by 30 days. Results may last up to 4 months.
Xeomin
The official Xeomin site describes results as appearing gradually, with most patients seeing noticeable improvement within the first month. Results can last up to 4 months.
For an individual patient, duration may vary with treatment area, dose, muscle strength, metabolism, prior treatment pattern and how the result is being measured. If your neuromodulator seems to wear off unusually quickly, the answer may involve dose or treatment design—not necessarily switching brands. See our guide to why Botox may not last as long as expected.
5. Which Looks More Natural: Botox or Xeomin?
Neither product has a monopoly on natural-looking results. A natural result comes from selecting the right muscles, using an appropriate dose, respecting brow and eyelid anatomy, preserving useful movement and avoiding treatment that exceeds the patient’s goal.
A heavy brow, overly arched “Spock” brow, asymmetric forehead or frozen expression is usually a treatment-planning problem before it is a brand problem. The same product can look elegant in one injection pattern and unnatural in another.
Related reading: Natural Botox vs Frozen Botox and Why Botox Can Look Heavy.
6. Botox vs Xeomin Cost in Reno
Price matters, but comparison only makes sense when you compare the total treatment being recommended. At Bella Derma, current package pricing as of September 2026 is:
Botox Cosmetic — 50 Units
$650 standard
$600 first-time patient pricing
Xeomin — 50 Units
$550 standard
$500 first-time patient pricing
Those numbers should not be interpreted as a recommendation that every patient needs 50 units—or that 50 units of one brand should be expected to create the exact same clinical effect as 50 units of another. Treatment is individualized.
For a deeper explanation of how neuromodulator pricing works, read our Botox cost per unit in Reno guide.
7. Who May Prefer Botox and Who May Prefer Xeomin?
There is no universal profile that makes one product the correct choice for everyone, but there are reasonable situations where a patient and provider may lean one way.
Botox may be worth considering when:
• You have used Botox before and like your response
• You value its long cosmetic track record
• Your treatment goal includes an FDA-approved Botox-specific area such as platysma bands
• You participate in or prefer the Allē rewards ecosystem
• Your injector believes Botox best matches the planned treatment
Xeomin may be worth considering when:
• You have used Xeomin before and like your response
• You prefer a product manufactured without complexing proteins
• Your goals are within the upper-face areas currently included in Xeomin’s cosmetic labeling
• Price makes Xeomin attractive within the recommended treatment plan
• Your injector believes Xeomin is a good fit for your anatomy and history
A brand preference is valid. A brand obsession is not necessary.
If you have had excellent results with one product, there is often no compelling reason to change simply because another toxin is trending online. If your results have been inconsistent, the right next step is to examine dose, placement, treatment area, timing and medical history before assuming the brand is the problem.
8. Can You Switch From Botox to Xeomin—or Back Again?
Yes, patients can be treated with different botulinum toxin products over time when medically appropriate. Your provider should know which product you received, when you received it, the areas treated, the approximate dose and how you responded.
Do not treat switching as a casual same-week experiment. Both Botox and Xeomin safety information tells patients to inform their provider about botulinum toxin treatment received within the prior four months. A responsible injector will consider timing and cumulative treatment before recommending another session.
9. Safety: Both Are Prescription Medicines, Not Beauty Products
Botox Cosmetic and Xeomin carry important safety information, including boxed warnings about the potential spread of toxin effect. Serious problems with swallowing, speaking or breathing can occur and require urgent medical attention. Patients should discuss neuromuscular disorders, prior botulinum toxin reactions, medications, pregnancy or breastfeeding, planned surgery, infection at the injection site and other relevant medical history before treatment.
Common cosmetic side effects may include injection-site discomfort or bruising, headache and temporary unwanted muscle effects such as eyelid or brow changes, depending on the product and treatment area.
The safest toxin is the one used appropriately.
Product authenticity, medical screening, storage and preparation, dose, injection anatomy, informed consent and complication management all matter. A discount does not compensate for weak clinical judgment.
Why Injector Skill Matters More Than the Botox-vs-Xeomin Debate
Neuromodulators do not decide where to place themselves. The injector decides which muscles to treat, which muscles to preserve, how much product to use, how high or low to place injections, how to respond to asymmetry and when treatment should be deferred.
This matters most in the forehead, where the frontalis muscle helps elevate the brows. Treating the forehead without understanding brow position can create heaviness. It also matters around the eyes, lower face and jaw, where nearby muscles perform important functions.
For first-time patients, an excellent consultation should include facial movement assessment, treatment goals, discussion of risks and realistic expectations—not just the question, “Botox or Xeomin?”
See our Reno Botox Consultation Checklist and our guide to when Botox is the wrong treatment.
How Bella Derma Chooses Between Botox and Xeomin
Bella Derma offers both Botox Cosmetic and Xeomin because product choice should follow the patient—not the other way around. During consultation, May evaluates your facial anatomy, movement pattern, treatment history, goals, preferred degree of movement, prior duration, budget and the areas you want treated.
Sometimes the answer is Botox. Sometimes it is Xeomin. Sometimes the better answer is a smaller treatment, a different treatment area, a different modality—or no neuromodulator yet.
BELLA DERMA PRINCIPLE
Right treatment. Right dose. Right placement. Right time.
Brand selection matters, but the treatment plan matters more. If Botox or Xeomin is not the right tool for the problem, we would rather explain that than sell the wrong procedure.
Frequently Asked Questions About Botox vs Xeomin
Is Xeomin better than Botox?
Not universally. Both are established botulinum toxin type A products. The better choice depends on the treatment area, your history, your goals and the injector’s plan.
Does Xeomin last longer than Botox?
Neither product should be promised to last longer in every patient. Official consumer information for both products describes effects that may last up to about four months, while individual duration varies.
Does Botox work faster than Xeomin?
Botox Cosmetic’s official site says results may begin in 24–48 hours, while Xeomin’s consumer information describes gradual improvement with most patients noticing improvement within the first month. Individual onset varies, and early visible change is not the same as the final treatment result.
Is Xeomin more natural-looking?
A natural look is primarily created by dose, placement, muscle selection and treatment goals. Either product can look subtle and natural when appropriately used.
Can I switch from Botox to Xeomin if Botox stopped working?
Possibly, but reduced response should first be evaluated carefully. Dose, placement, timing, muscle strength and treatment expectations can all create the impression that a toxin “stopped working.” True secondary nonresponse is a medical issue worth discussing with an experienced provider.
Are 20 units of Botox the same as 20 units of Xeomin?
They should not be treated as interchangeable simply because the numbers match. Each product’s units are defined by its own biological potency assay and labeling. Your provider should use product-specific dosing.
Which is cheaper at Bella Derma?
As of September 2026, Bella Derma’s 50-unit Xeomin package is priced lower than the 50-unit Botox package. The correct comparison, however, is the total treatment plan recommended for you—not unit price alone.
BOTOX OR XEOMIN?
You do not need to decide before your consultation.
Tell us what you want to improve and how natural you want the result to look. We will evaluate your anatomy, movement and treatment history, explain the options, and recommend the product and dose that make the most sense for you.
Schedule Your ConsultationAbout May Belle Fellenz
May Belle Fellenz, APRN, MSN, FNP-BC
Founder and Lead Medical Aesthetics Provider · Bella Derma Skin Care Solutions
May Belle Fellenz is a board-certified family nurse practitioner who leads Bella Derma Skin Care Solutions in Reno, Nevada. Her approach emphasizes individualized assessment, patient education, conservative treatment planning, and referral when a concern requires another specialist. At Bella Derma, the goal is the right treatment, at the right time, in the right sequence.